SCHEMBL6410833

SCHEMBL6410833

CCn1c(SCc2ccccc2)nnc1-c1ccc(OC)cc1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.76
▸ TSHR P16473 5/20 0.76
▸ ALDH1A1 P00352 5/20 0.72
▸ NPC1 O15118 2/20 0.72
▸ RAB9A P51151 1/20 0.72
▸ CYP1A2 P05177 4/20 0.65
▸ CYP2C19 P33261 4/20 0.65
▸ CYP2D6 P10635 3/20 0.65
▸ SMN1; SMN2 Q16637 3/20 0.65
▸ CYP2C9 P11712 2/20 0.65
▸ MEN1 O00255 5/20 0.65
▸ KMT2A Q03164 5/20 0.65
▸ LMNA P02545 3/20 0.63
▸ KDM4E B2RXH2 3/20 0.63
▸ HTT P42858 2/20 0.59
▸ GAA P10253 3/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ MAPT P10636 1/20 0.57
▸ PKM P14618 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4206332 0.94 CYP3A4 (0.86) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4205527 0.92 TSHR (0.69) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4205988 0.88 CYP3A4 (0.77) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4216551 0.88 CYP3A4 (0.77) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL3904873 0.86 TSHR (0.67) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4215474 0.86 CYP3A4 (0.73) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4199189 0.86 CYP3A4 (0.73) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4204004 0.86 TSHR (0.73) CYP3A4TSHRALDH1A1CYP1A2CYP2C19
SCHEMBL4212550 0.85 CYP3A4 (0.76) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL4210981 0.85 KMT2A (0.72) CYP3A4TSHRALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CYP3A4 25/4885TSHR 3470/4885ALDH1A1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback